| Original language | English |
|---|---|
| Pages (from-to) | e80-e81 |
| Journal | Journal of Dermatology |
| Volume | 48 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 2021 |
Durable remission after rechallenge with ipilimumab and nivolumab in metastatic Merkel cell carcinoma refractory to avelumab: Any role for sequential immunotherapy?
Karam Khaddour, Ilana S. Rosman, Farrokh Dehdashti, George Ansstas
- Division of Dermatology
- Division of Nuclear Medicine
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Section of Medical Oncology
- Institute for Public Health
- Department of Radiology
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Rheumatic Diseases Research Resource-Based Center
- Mentorship to Enhance Diversity in Academia (MEDA)
Research output: Contribution to journal › Letter › peer-review
12
Scopus
citations